136 related articles for article (PubMed ID: 25405516)
21. Antitumor activity of ginsenoside Rg3 in melanoma through downregulation of the ERK and Akt pathways.
Meng L; Ji R; Dong X; Xu X; Xin Y; Jiang X
Int J Oncol; 2019 Jun; 54(6):2069-2079. PubMed ID: 31081060
[TBL] [Abstract][Full Text] [Related]
22. Elevated STAT3 expression in ovarian cancer ascites promotes invasion and metastasis: a potential therapeutic target.
Saini U; Naidu S; ElNaggar AC; Bid HK; Wallbillich JJ; Bixel K; Bolyard C; Suarez AA; Kaur B; Kuppusamy P; Hays J; Goodfellow PJ; Cohn DE; Selvendiran K
Oncogene; 2017 Jan; 36(2):168-181. PubMed ID: 27292260
[TBL] [Abstract][Full Text] [Related]
23. Ginsenoside Rg3 inhibition of vasculogenic mimicry in pancreatic cancer through downregulation of VE‑cadherin/EphA2/MMP9/MMP2 expression.
Guo JQ; Zheng QH; Chen H; Chen L; Xu JB; Chen MY; Lu D; Wang ZH; Tong HF; Lin S
Int J Oncol; 2014 Sep; 45(3):1065-72. PubMed ID: 24938458
[TBL] [Abstract][Full Text] [Related]
24. Cryptotanshinone suppresses cell proliferation and glucose metabolism via STAT3/SIRT3 signaling pathway in ovarian cancer cells.
Yang Y; Cao Y; Chen L; Liu F; Qi Z; Cheng X; Wang Z
Cancer Med; 2018 Sep; 7(9):4610-4618. PubMed ID: 30094960
[TBL] [Abstract][Full Text] [Related]
25. [Ginsenoside 20(S)-Rg3 upregulates tumor suppressor VHL gene expression by suppressing DNMT3A-mediated promoter methylation in ovarian cancer cells].
Wang L; Han X; Zheng X; Zhou Y; Hou H; Chen W; Li X; Zhao L
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Jan; 41(1):100-106. PubMed ID: 33509760
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of STAT3 signaling as critical molecular event in resveratrol-suppressed ovarian cancer cells.
Zhong LX; Li H; Wu ML; Liu XY; Zhong MJ; Chen XY; Liu J; Zhang Y
J Ovarian Res; 2015 Apr; 8():25. PubMed ID: 25896424
[TBL] [Abstract][Full Text] [Related]
27. 20(S)-Rg3 upregulates FDFT1 via reducing miR-4425 to inhibit ovarian cancer progression.
Lu J; Zhou Y; Zheng X; Chen L; Tuo X; Chen H; Xue M; Chen Q; Chen W; Li X; Zhao L
Arch Biochem Biophys; 2020 Oct; 693():108569. PubMed ID: 32877662
[TBL] [Abstract][Full Text] [Related]
28. Silencing of the STAT3 signaling pathway reverses the inherent and induced chemoresistance of human ovarian cancer cells.
Han Z; Feng J; Hong Z; Chen L; Li W; Liao S; Wang X; Ji T; Wang S; Ma D; Chen G; Gao Q
Biochem Biophys Res Commun; 2013 May; 435(2):188-94. PubMed ID: 23665025
[TBL] [Abstract][Full Text] [Related]
29. Pivotal Roles of Ginsenoside Rg3 in Tumor Apoptosis Through Regulation of Reactive Oxygen Species.
Sun HY; Lee JH; Han YS; Yoon YM; Yun CW; Kim JH; Song YS; Lee SH
Anticancer Res; 2016 Sep; 36(9):4647-54. PubMed ID: 27630307
[TBL] [Abstract][Full Text] [Related]
30. Ginsenoside Rg3-induced EGFR/MAPK pathway deactivation inhibits melanoma cell proliferation by decreasing FUT4/LeY expression.
Shan X; Aziz F; Tian LL; Wang XQ; Yan Q; Liu JW
Int J Oncol; 2015 Apr; 46(4):1667-76. PubMed ID: 25672851
[TBL] [Abstract][Full Text] [Related]
31. Nitidine chloride inhibits hepatocellular carcinoma cell growth in vivo through the suppression of the JAK1/STAT3 signaling pathway.
Liao J; Xu T; Zheng JX; Lin JM; Cai QY; Yu DB; Peng J
Int J Mol Med; 2013 Jul; 32(1):79-84. PubMed ID: 23613111
[TBL] [Abstract][Full Text] [Related]
32. Signal transducers and activators of transcription 3 pathway activation in drug-resistant ovarian cancer.
Duan Z; Foster R; Bell DA; Mahoney J; Wolak K; Vaidya A; Hampel C; Lee H; Seiden MV
Clin Cancer Res; 2006 Sep; 12(17):5055-63. PubMed ID: 16951221
[TBL] [Abstract][Full Text] [Related]
33. Specific Pyruvate Kinase M2 Inhibitor, Compound 3K, Induces Autophagic Cell Death through Disruption of the Glycolysis Pathway in Ovarian Cancer Cells.
Park JH; Kundu A; Lee SH; Jiang C; Lee SH; Kim YS; Kyung SY; Park SH; Kim HS
Int J Biol Sci; 2021; 17(8):1895-1908. PubMed ID: 34131394
[TBL] [Abstract][Full Text] [Related]
34. Pien Tze Huang inhibits tumor cell proliferation and promotes apoptosis via suppressing the STAT3 pathway in a colorectal cancer mouse model.
Zhuang Q; Hong F; Shen A; Zheng L; Zeng J; Lin W; Chen Y; Sferra TJ; Hong Z; Peng J
Int J Oncol; 2012 May; 40(5):1569-74. PubMed ID: 22218594
[TBL] [Abstract][Full Text] [Related]
35. [Antiangiogenesis of ginsenoside Rg3 in severe combined immunodeficient mice with human ovarian carcinoma].
Pan Z; Ye D; Xie X; Chen H; Lu W
Zhonghua Fu Chan Ke Za Zhi; 2002 Apr; 37(4):227-30. PubMed ID: 12133417
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-216a inhibits pancreatic cancer by directly targeting Janus kinase 2.
Wang S; Chen X; Tang M
Oncol Rep; 2014 Dec; 32(6):2824-30. PubMed ID: 25220761
[TBL] [Abstract][Full Text] [Related]
37. Anti-Warburg effect of rosmarinic acid via miR-155 in gastric cancer cells.
Han S; Yang S; Cai Z; Pan D; Li Z; Huang Z; Zhang P; Zhu H; Lei L; Wang W
Drug Des Devel Ther; 2015; 9():2695-703. PubMed ID: 26056431
[TBL] [Abstract][Full Text] [Related]
38. A novel miR-155/miR-143 cascade controls glycolysis by regulating hexokinase 2 in breast cancer cells.
Jiang S; Zhang LF; Zhang HW; Hu S; Lu MH; Liang S; Li B; Li Y; Li D; Wang ED; Liu MF
EMBO J; 2012 Apr; 31(8):1985-98. PubMed ID: 22354042
[TBL] [Abstract][Full Text] [Related]
39. LB-1 Exerts Antitumor Activity in Pancreatic Cancer by Inhibiting HIF-1α and Stat3 Signaling.
Niu F; Li Y; Lai FF; Ni L; Ji M; Jin J; Yang HZ; Wang C; Zhang DM; Chen XG
J Cell Physiol; 2015 Sep; 230(9):2212-23. PubMed ID: 25655308
[TBL] [Abstract][Full Text] [Related]
40. Pyruvate kinase M2 is a poor prognostic marker of and a therapeutic target in ovarian cancer.
Chao TK; Huang TS; Liao YP; Huang RL; Su PH; Shen HY; Lai HC; Wang YC
PLoS One; 2017; 12(7):e0182166. PubMed ID: 28753677
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
